Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label ruxolitinib. Show all posts
Showing posts with label ruxolitinib. Show all posts
Tuesday, September 15, 2015

Targeted drug can ‘diminish the suffering’ of myelofibrosis

›
Investigators further found that pacritinib could be used safely in patients with myelofibrosis who have thrombocytopenia, a life-threati...
Friday, September 11, 2015

JAK2 inhibitor ruxolitinib shows promise in treating CMML patients

›
In continuation of my update on  Ruxolitinib Chronic myelomonocytic leukemia (CMML) is a rare type of myelodysplastic, myeloproli...
Saturday, March 3, 2012

New Drug, Ruxolitinib May Help Fight Rare Bone Marrow Disorder

›
In continuation of my update on ruxolitinib New Drug May Help Fight Rare Bone Marrow Disorder : WEDNESDAY, Feb. 29 -- Two new studies confi...
Monday, August 8, 2011

FDA Accepts NDA Filing for Ruxolitinib as a Treatment for Myelofibrosis

›
FDA Accepts NDA Filing for Ruxolitinib as a Treatment for Myelofibrosis
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.